Aesthetics

Safety, Tolerability, and Efficacy of Repeat-Dose Injections of IncobotulinumtoxinA in the Treatment of Upper Facial Lines: Results from a Prospective, Open-Label, Phase III Study

By April 29, 2020No Comments

Dermatology News

"Safety, Tolerability, and Efficacy of Repeat-Dose Injections of IncobotulinumtoxinA in the Treatment of Upper Facial Lines: Results from a Prospective, Open-Label, Phase III Study"

IncobotulinumtoxinA (Xeomin/Xeomeen/Bocouture/XEOMIN Cosmetic; botulinum toxin type A free from complexing proteins [150 kDa]; Merz Pharmaceuticals GmbH) is indicated worldwide for the correction of glabellar frown lines (GFL) and in Europe additionally for lateral periorbital lines (LPL; crow’s feet) and upper facial lines (UFL; ie, simultaneous treatment of GFL, LPL, and horizontal forehead lines [HFL]).1

The efficacy of incobotulinumtoxinA in the treatment of multiple or singular facial areas has been extensively demonstrated.2-10 With the recent surge in interest for a more holistic approach, consisting of combined treatment of GFL, HFL, and LPL in a single treatment session, there is a need for demonstrating safety and efficacy for such procedures.

This study provides strong evidence for the safety and tolerability of repeat-dose treatments with incobotulinumtoxinA in UFL (GFL, 20 U; HFL, 10-20 U; LPL, 24 U). A stable safety profile was demonstrated during prolonged administration and a noteworthy trend to better tolerability with continued use of incobotulinumtoxinA was established

Read More

You May Also Like

Dermatology Roundup: Medicare Fee Schedule to Cut Physician Pay; Telemedicine Tool Found Accurate in Melanoma Diagnosis

| Atopic Dermatitis, Dermatology Roundup, Global Health, JDD Highlights, JDD in the Media, Skin Cancer, The Latest | No Comments
By Allison Sit The American Academy of Dermatology (AAD) is joining with other specialties in speaking out about cuts to the Medicare Physician Fee Schedule for 2025. The physician services…

JDD in the News: Hyperhidrosis & Sensitive Skin Connection; Dermatitis from Poppers

| Acne, Derm Community, Featured Articles, JDD Highlights, JDD in the Media, The Latest | No Comments
By Allison Sit Dermatology Advisor and Physician’s Weekly each shared a HealthDay article about a JDD study on a possible relationship between hyperhidrosis and sensitive skin. The study, “Primary Hyperhidrosis…
The Full Spectrum of Dermatology: A Diverse and Inclusive Atlas picture collection for drug reaction with eosinophilia and systemic symptoms, showcasing the condition in side by side multiple skin tones. Images and pictures of DRESS. Dermal, inflammatory, eosinophilic dermatology skin condition. Inclusive Derm Atlas, diversity in skin types. Skin of color included.

Decoding Derm: What’s the Diagnosis

| Inclusive Dermatology Atlas, JDD Highlights, The Latest, Video Pearls | No Comments
Decoding Derm Series from the Inclusive Derm Atlas Join Dr. Alexis Carrington in Decoding Dermatology: What's the Diagnosis, as she presents a curated image collection from The Full Spectrum of…

Leave a Reply